Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
16,519,945
-
Share change
-
+696,695
-
Total reported value
-
$33,039,000
-
Put/Call ratio
-
137%
-
Price per share
-
$2.00
-
Number of holders
-
44
-
Value change
-
+$1,383,504
-
Number of buys
-
15
-
Number of sells
-
15
Institutional Holders of SUNESIS PHARMACEUTICALS INC - COM PAR (SNSS) as of Q3 2018
As of 30 Sep 2018,
SUNESIS PHARMACEUTICALS INC - COM PAR (SNSS) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,519,945 shares.
The largest 10 holders included
EVENTIDE ASSET MANAGEMENT, LLC, Balyasny Asset Management LLC, BOXER CAPITAL, LLC, BVF INC/IL, NEA Management Company, LLC, Palo Alto Investors LP, Vanguard Group Inc, GREAT POINT PARTNERS LLC, BAKER BROS. ADVISORS LP, and RHENMAN & PARTNERS ASSET MANAGEMENT AB.
This page lists
44
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.